We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
12801
PUT
DELISTED
Applied Genetic Technologies Corporation
AGTC
$98K ﹤0.01%
32,600
-20,500
-39% -$73K
AVAN.WS
12802
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$98K ﹤0.01%
150,087
+87
+0.1% +$75
VTAQR
12803
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$98K ﹤0.01%
562,736
-68,888
-11% -$14.4K
CRMD icon
12804
CorMedix
CRMD
$583M
$97K ﹤0.01%
20,833
-9,287
-31% -$54.1K
FPH icon
12805
CALL
Five Point Holdings
FPH
$377M
$97K ﹤0.01%
12,400
-8,700
-41% -$70.6K
FRSX
12806
CALL
Foresight Autonomous Holdings
FRSX
$3.76M
$97K ﹤0.01%
247
-163
-40% -$68.9K
LXRX icon
12807
PUT
Lexicon Pharmaceuticals
LXRX
$991M
$97K ﹤0.01%
20,200
-6,200
-23% -$25.4K
PANL icon
12808
CALL
Pangaea Logistics
PANL
$488M
$97K ﹤0.01%
+19,200
New +$94.2K
VOC icon
12809
CALL
VOC Energy
VOC
$50.1M
$97K ﹤0.01%
21,200
+6,500
+44% +$28.7K
BFI
12810
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$97K ﹤0.01%
11,250
-35,310
-76% -$362K
PRTK
12811
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$97K ﹤0.01%
20,000
+1,100
+6% +$6.06K
INFI
12812
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$97K ﹤0.01%
28,300
+5,500
+24% +$17K
ACOR
12813
CALL
DELISTED
Acorda Therapeutics
ACOR
$97K ﹤0.01%
1,055
+510
+94% +$42.3K
BLCM
12814
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$97K ﹤0.01%
33,252
-365
-1% -$1.11K
PDOT.WS
12815
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$97K ﹤0.01%
120,176
-1,853
-2% -$1.95K
MACC.WS
12816
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$97K ﹤0.01%
166,666
-873
-0.5% -$610
VOSOW
12817
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$97K ﹤0.01%
84,820
-468,917
-85% -$607K
ADTX
12818
PUT
DELISTED
ADITXT INC
ADTX
0
DHY
12819
Credit Suisse High Yield Credit Fund
DHY
$240M
$96K ﹤0.01%
+38,950
New +$97.8K
INOD icon
12820
CALL
Innodata
INOD
$2.13B
$96K ﹤0.01%
+10,100
New +$77.4K
OXSQ icon
12821
CALL
Oxford Square Capital
OXSQ
$159M
$96K ﹤0.01%
23,700
-3,600
-13% -$16.4K
RBBN icon
12822
Ribbon Communications
RBBN
$375M
$96K ﹤0.01%
16,105
-52,262
-76% -$353K
SVM
12823
CALL
Silvercorp Metals
SVM
$2.04B
$96K ﹤0.01%
25,300
-38,900
-61% -$176K
SXC icon
12824
CALL
SunCoke Energy
SXC
$686M
$96K ﹤0.01%
15,300
-10,700
-41% -$73.5K
DXYN
12825
CALL
DELISTED
Dixie Group Inc
DXYN
$96K ﹤0.01%
19,700
-9,300
-32% -$36.3K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.